Measurement of Acute Metabolite Changes Following Consumption of Microalgae Drinks

Inclusion Criteria: * English-literate and able to give informed consent * Singaporean Chinese Adults aged 21 to 60 (inclusive) * Body mass index of 18.5 to 23.0 kg/m\^2 (inclusive) * Healthy (Based on results from screening session) Exclusion Criteria: * Currently participating in another clinical study that involves altering the regular diet and/or involves consuming a dietary supplement or investigated food product as an intervention * High blood pressure (≥ 140/90 mmHg) * Underlying health conditions that may affect metabolic functions * Consuming amino acid or protein supplements, or protein drinks, regularly (i.e., more than three times a week) for the past 3 months, and not willing to discontinue usage 3 months before and during the study duration * Weight change \> 3 kg in the past 3 months * Weight \< 50 kg * Exercising vigorously over the past 3 months (i.e., engaging in high-intensity exercises for more than 3 hours a week, where high-intensity exercises leave one out of breath and unable to talk or sing during the workout) * Current smokers or have quit smoking for less than 5 years * Drinking \> 2 alcoholic drinks per day (i.e., one drink is defined as either 150 ml of wine, 340 ml of beer/cider or 45 ml of distilled spirit) * If drinking ≤ 2 alcoholic drinks per day, not willing to stop consumption of alcoholic beverages two days before and on the day of the test visits * Not willing to stop consumption of caffeinated beverages 10 to 12 houFrs before and on the day of the test visits * Currently on a specialised diet (e.g., Halal, vegetarian, vegan, weight loss diet) * Had serious food allergies in the past, or having intolerance, sensitivities or allergies to any of the following: seaweed or algae and their derived products, milk/dairy products (e.g., whey), starch/starch-derived products (e.g., rice, corn, wheat, potato), soy/soy-derived products, gluten, eggs, nuts, peanuts, fish and crustaceans * Disease or impairment of the kidney and/or liver\* * Currently diagnosed with diabetes\*, gastrointestinal issues (e.g., lactose intolerance, irritable bowel syndrome), gout and/or G6PD deficiency * Taking antibiotics 2 weeks prior to study participation * Taking anti-hypertensive or cholesterol-lowering drugs for less than 3 years unless medically declared by an official doctor to be in stable condition * Poor peripheral venous access based on past experiences with blood drawing * Individuals with anemia and/or blood clotting disorders * Donated blood within the 12 weeks prior to study participation * Individuals with pacemaker or related electrical medical devices * Pregnant, lactating, or planning pregnancy in the next 6 months